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ABSTRACT 
 
In this study, characterization and development of polymer nanocomposites filament 
wire for Fused Deposition Modelling (FDM) was investigated. The polycaprolactone 
(PCL) filled montmorillonite (MMT) and Hydroxyapaptite (HA) composites were 
prepared by melting and compounding using a single screw extruder. The 
mechanical properties were assessed by tensile, flexural and charpy impact tests 
while the thermal properties were studied via differential scanning calorimetry 
(DSC) and thermogravimetry analyzer (TGA). Simulated body fluid (SBF) test was 
used to assess the bioactivity properties of the composites. The filament wire with 
the diameter of 1.75+0.05 were fabricated using a single screw extruder with die hole 
1.6 mm in diameter. Design of experiment (DOE) software was used to find the 
optimum setting for the screw speed, roller speed and die temperature in order to 
achieve the specific diameter of the filament wire. The flexural strength, elastic 
modulus and flexural modulus of PCL/MMT blends increased with the decrement of 
tensile strength and impact strength. Apparently, the inclusion of HA upon PCL/ 
MMT composite shows a slight improvement in elastic modulus, flexural modulus 
and flexural strength with reduction of impact strength. Addition of MMT and HA 
enhanced the thermal stability and the decomposition temperature of the composites. 
Formation of apatite crystals on the PCL/MMT/HA composites surfaces confirmed 
the occurrence of bioactive properties. Composites with 3 wt.% of MMT and 10 
wt.% of HA were chosen as optimum composition in terms of strength and bioactive 
properties to be fabricated as filament wire for FDM process. The optimum 
parameter setting to produce 1.75+0.05 of filament wire was successfully found at 
screw speed of 7.30 Hz, roller speed of 4.3 rpm and die temperature of 90°C. The 
characteristic of the FDM process shows that the samples with optimum dimensional 
accuracy and relative density was found at room temperature and 80°C of platform 
and nozzle temperature respectively. The composites with 3 wt.% of MMT and 10 
wt.% of HA samples produced from the FDM process show an improvement in 
elastic modulus and impact strength compared to samples prepared by injection 
molding process.  
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ABSTRAK 
 
 
Dalam kajian ini, pencirian dan penghasilan polimer nanokomposit wayar filamen 
untuk pemodelan pemendapan bersatu (FDM) telah dikaji. Polimer polycaprolactone 
(PCL) diisi montmorilonit (MMT) dan hydroxyapaptite (HA) komposit telah 
disediakan dengan penyebatian leburan menggunakan pemyemperit skru tunggal. 
Sifat-sifat mekanik dikaji melalui ujian regangan, lenturan dan hentaman manakala 
sifat terma dianalisa menggunakan kalorimeter pengimbasan perbezaan (DSC) dan 
penganalisis termogravimetri (TGA). Ciri- ciri bioaktiviti PCL/MMT/HA komposit 
dikaji melalui ujian secara rendaman ke dalam cecair badan simulasi (SBF). Wayar 
filamen berdiameter 1.75 + 0.05 telah dihasilkan menggunakan penyemperit skru 
tunggal dengan lubang acuan berdiamater 1.6 mm. Perisian reka bentuk eksperimen 
(DOE) digunakan untuk mencari tetapan yang optima bagi kelajuan penggelek, 
kelajuan skru dan suhu acuan untuk mencapai diameter yang tepat bagi wayar 
filamen. Kekuatan lenturan, modulus elastik dan modulus lenturan PCL/MMT 
meningkat dengan susutnya kekuatan tegangan dan kekuatan hentaman. Penambahan 
HA di dalam PCL/MMT komposit menunjukkan sedikit peningkatan pada modulus 
elastik, modulus lenturan dan kekuatan lenturan dengan pengurangan kekuatan 
hentaman. Penambahan MMT dan HA juga meningkatkan kestabilan terma dan suhu 
penguraian bagi komposit. Pembentukan kristal apatit pada permukaan komposit 
PCL/MMT/HA mengesahkan berlakunya sifat bioaktif. Komposit dengan campuran 
3 wt.% MMT an 10 wt.% HA dipilih sebagai komposisi yang optima dari segi 
kekuatan dan sifat bioaktif yang akan direka sebagai wayar filamen bagi proses 
FDM. Parameter optima untuk menghasilkan 1.75 + 0.05 wayar filamen daripada 
komposit PCL/MMT/HA adalah dengan kelajuan skru 7.30 Hz, kelajuan penggelek 
pada 4.3 rpm dan suhu acuan pada 90°C. Ciri-ciri ketumpatan relative dan ketepatan 
dimensi yang optima bagi sampel yang dihasilkan daripada proses FDM adalah pada 
suhu landasan dan muncung pada 0°C dan 80°C masing-masing. Sampel 3 wt.% 
MMT an 10 wt.% HA yang dihasilkan dengan proses FDM menunjukkan 
peningkatan pada modulus elastic dan kekuatan hentaman berbanding dengan sampel 
yang dihasilkan dengan proses pengacuan suntikan. 
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CHAPTER 1 
 
 
 
 
INTRODUCTION 
 
 
 
 
1.1 Background 
 
 
Additive Manufacturing (AM) is a technique of manufacturing in which a solid 
physical model of a part is made directly from a three-dimensional computer-aided 
design (CAD) file. AM techniques such as selective laser sintering (SLS), 
stereolithography (SLA), three-dimensional printing (3DP), laminated object 
manufacturing (LOM), and fused deposition modeling (FDM) were first developed 
to create prototypes for purposes of designing a new product. Later, with the progress 
of material and enabling technology, these AM techniques emerged out and have 
been applied in the fields such as rapid tooling and molding, direct formed usable 
part, and bio-manufacturing (Chua, 2003) 
Fused deposition modelling (FDM) has become a widely used additive 
manufacturing technology for various applications in engineering. The uniqueness of 
FDM technique is more economical for small to medium size parts in the shortest 
lead time, it is because SLA and SLS use resin to build models and it deteriorates 
over time and also it uses a laser which depreciates over time making it difficult to 
ensure repeatability. Apart from that, with the recent introduction of portable 3D 
printer, it makes it more popular as it is easy to use and user friendly compared to 
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other type of the AM process. But typically the part produce is not strong enough, or 
some other material property is not suitable for the application.  
Now, FDM has progressed one step further from fabricating a prototype to a 
fully functional product. One of the key industries that shows a huge impact in 
emerging of this technology are medical industries (Espalin et al., 2010). The 
strongest reason is because of the ease in which 3D medical imaging data can be 
converted into solid objects. In this way the objects or product can be customized to 
suit the needs of an individual patient. This eventually led to a reduction in cost of 
production of an implant and other medical instruments which significantly reduce 
the cost that have to be charged over most of the patients. Presently most of the 
research work is directed toward developing new materials or processes which target 
on mechanical properties improvement of parts produced from FDM and 
biocompatible polymers are one of the material  that have been top choices for most 
researchers. (Masood, 1996; Woodruff & Hutmacher, 2010). 
There are a lot of different types of biocompatible polymers nowadays that 
have been investigated by most of the researcher associate with FDM and one of the 
most famous biopolymer is Polycaprolactone (PCL). Polycaprolactone (PCL) is a 
semicrystal-line polyester and highly processible as it is soluble in a wide range of 
organic solvents. It has a relatively low melting point (55 - 60°C) and glass transition 
temperature -60°C and the more important that it has the ability to form miscible 
blends with a wide range of polymers has stimulated extensive research into its 
potential application in the biomedical field (Nair & Laurencin, 2007). PCL have 
been major acceptance in the tissue engineering field. The properties of PCL which 
possesses superior viscoelastic and rheological properties over other bioploymer 
make it easy to be manufactured and manipulate into a large range of scaffolds. 
Scaffolds for tissue engineering have become a large focus of research 
attention and can be fabricated in a wide variety of ways and a biomaterial which 
lends itself very well to scaffold fabrication is PCL. PCL is an incredibly versatile 
bioresorbable polymer and by way of its superior rheological properties it can be 
used by almost any polymer processing technology to produce an enormous array of 
scaffolds. 
As the material development effort progresses by time, composites 
approaches comes into action to continue to improve the properties whilst 
maintaining material characteristics required for producing products. The key 
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development for direct manufacturing of parts from FDM has been the incorporation 
of additives to polymer matrix material to enhance the mechanical properties of the 
resulting parts. There are many efforts underway to develop high-performance, rapid 
prototyping materials with promise for engineering applications, including enhanced 
mechanical properties (Zhang et al., 2004; Wang et al., 2005; and Koo et al., 2006) 
by using polymer nanocomposites (PNCs) material. PNCs are based on controlling 
microstructure by incorporating nanometer-size as second-phase dispersions into 
polymer matrixes (Vollath & Szabo, 2004). PNCs have emerged as materials which 
can show significantly enhanced mechanical properties over those of the base 
polymer through the addition of relatively small amounts of nano-scale additives. 
Improvements in strength and modulus of 40-70% have been reported to have arisen 
as a result of the addition of 2-5wt% of nano clay (Pavlidou & Papaspyrides, 2008).  
 A part of improving the mechanical properties of polymers by the addition of 
nanoclay, the current filament wire used in FDM is also not bioactive. The filament 
wires currently available and being investigated by researchers for FDM is only 
biocompatible, which can only adapt in the human body without regenerating the 
tissues. Much attention has been paid towards the development of polymer 
composites with hydroxyaptite (HA) as bioactive material in bone tissue engineering 
(Wang et al., 1997; Fang et al., 2006). Applying of HA filler particles to form 
composites has been shown to enhance bone-bonding rates. The emerging interest of 
using HA is due to its chemical and structural similarity with natural bone mineral. 
Due to its bioactive traits, HA has the ability to integrate into bone structures and 
support bone growth. The addition of Ca-P ceramic to the polymer makes a 
composite bone analogue and improves the bone bonding behavior of unﬁlled 
polymers (Gomes & Reis, 2004). Calcium phosphate increases the osteoconductivity 
of the biocomposite (Murphy et al., 1999). It has been found that the right amount of 
HA is required to enhance the bioactivity of polymers without making the 
composites fragile. This can promise a positive result in producing a bioactive 
filament wire for FDM process. 
At present, most of the research on FDM has focused on producing a medical 
device and great attention of studies has been paid in material development for FDM 
process. So far there is no work has been done on producing composites by 
incorporation of both MMT and HA with biopolymer. 
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Therefore, this work introduces MMT and HA as a filler in PCL to improve 
the properties of filament wire composites for FDM. With reinforcement of MMT, 
which will enhance the mechanical properties of the filament wire composite 
meanwhile the incorporation of HA, offers special properties as a particulate 
bioactive phase in biomedical composites. Thus, this research focuses on the 
preparation of PCL/MMT/HA filament wire nanocomposites for FDM with both 
mechanical and bioactive properties.  
 
 
1.2 Problem statement 
 
 
Most of medical parts today are still made by conventional method such as 
machining and injection molding. There are a lot of disadvantages using this method 
as it is not economical because it involves in fabricating a mold to produces a parts. 
Secondly, it is time consuming as the whole process from manufacturing until 
producing the parts takes a lot of time and finally, each molds only specific for each 
person, where different patient needs a different mold. However, using AM 
technique all these problems can be overcome as there no needs of mold fabrication 
and more towards customize medical parts. But, there are certain limitation using 
AM techniques, where current AM technique produces prototypes from pure 
polymer materials resulting in limited uses especially in medical industries. 
A good combination of mechanical properties, processability and bioactivity 
properties with absence of toxic together with manufacturing techniques is an 
important aspect in the development of biomaterials for biomedical applications 
using FDM technique. In terms of mechanical properties, composite with high 
modulus (elastic as well as flexural modulus) and strength is expected to produce for 
medical applications.  
Introduction of polymer nanocomposites for the FDM process may be one of 
the best options that could overcome this problem. The incorporation of MMT 
provides an alternative choice to improved the PCL/MMT composite mechanical 
properties as it has been proven that by the addition of small amounts of MMT led to 
an improvement of the mechanical properties of a composite (Pavlidou & 
Papaspyrides, 2008).  
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Besides that, bioactive implant is one of the greatest interest in the medical 
field nowadays and reinforcing ceramic is one of the popular choices. Among 
ceramic materials, HA is widely used in implant material as it can favor the cell 
proliferation and support bone in growth. So far there is no such polymer 
nanocomposites material develops by incorporating MMT and HA into PCL for 
FDM process which seems to promise an interesting finding.  
 
 
1.3 Objectives of the study 
 
 
This study embarks on the following objectives: 
 
a. To investigate the effect of MMT content on the mechanical and 
thermal properties of PCL blends. 
b. To evaluate the effect of HA concentration on the mechanical, thermal 
and bioactivity properties of PCL/MMT composites blends.  
c. To optimize parameters setting for fabrication of the filament wire for 
the FDM process from PCL/MMT/HA composite using Response 
Surface Methodology (RSM).  
d. To develop PCL/MMT/HA filament wire nanocomposites for FDM 
process. 
e. To investigate the effect of FDM processing temperature (nozzle and 
platform) on the quality of product produce from PCL/MMT/HA using 
FDM process. 
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1.4 Scope of the study 
 
 
This study will focus on:- 
 
a. Preparing samples through:  
i. Dry blending. 
ii. Extrusion of composites using single screw extruder nanomixer. 
b. The PCL, MMT and HA are mixed and tried in a different composition. 
c. Flexural test, tensile test and impact test will be carried out to determine 
the mechanical properties of the composites. 
d. SEM (Scanning Electron Microscopy) and TEM (Transmission Electron 
Microscopy) will be carried out to correlate the mechanical properties of 
the nano sized MMT reinforced PCL composites with the morphology 
(structure-property relationship). 
e. Determination of thermal properties by using: 
i. Differential Scanning Calorimetry (DSC). 
ii. Thermogravimetry Analysis (TGA). 
f. Evaluating the bioactivity properties of PCL/MMT/HA composites 
through immersion in simulated body fluid (SBF). 
g. Fabrication of PCL/MMT/HA filament wire through an extrusion process 
with the aid of roller puller and water bath. 
h. Optimize the parameter for fabricating PCL/MMT/HA composite filament 
wire using Design of Experiment (DOE). 
i. Analyzing the nozzle and platform temperature of FDM process through 
the dimensional error and relative density of bending sample. 
j. Produce the tensile, bending and impact test samples from 3D printer and 
compare with injection molding samples. 
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1.5 Novelty and significance of the study  
 
 
From this research, development of a new PCL/MMT/HA polymer nanocomposites 
for FDM process that have potential in producing biomedical implant application. 
The utilize of PCL/MMT/HA polymer nanocomposites for FDM process is expected 
to increase with the improvement of its mechanical and bioactivite properties by 
incorporation of MMT and HA. 
 
 
  
 
 
 
 
CHAPTER 2 
 
 
 
 
LITERATURE REVIEW 
 
 
 
 
2.1 Additive Manufacturing 
 
 
 Additive Manufacuring (AM) techniques were developed to create prototypes for 
purposes of  designing a new product. Traditional prototyping methods involve 
laborious mold making and casting steps (Pham and Gault.,  1998), whereas the 
ability to create an object within hours from a computer design by rapid prototyping 
(RP) signiﬁcantly speeds up the development of products. Currently, AM techniques 
is common practice in the automotive industry, for jewelry making and for designing 
end-user devices and appliances (Wendel et al., 2008). Also in designing surgical 
tools, implants and other biomedical devices, these additive fabrication methods have 
been used. Some other advantages of AM technology compared to conventional 
technologies are: 
a. Formation of objects with whatever point of geometrical complexity 
without the demand for any tooling or computer programming 
b. Fabrication of objects potentially from a mixture of materials and any 
composites, and the ability to even vary feed materials in a controlled way 
at any position in an object 
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c. Enhancing the scope of product growth with reduced cost and time in 
specific areas such as biomedical engineering, tooling development, and 
consumer products. 
 As AM fabrication technologies are continuously evolving, fabrication costs 
are decreasing and the properties of the manufactured parts are becoming better. 
Therefore, these techniques are more and more being used for the rapid 
manufacturing of products in small series. The time gain in product development, 
freedom of design and tool-free fabrication can outweigh the increased fabrication 
costs per item (Wendel et al., 2008).  
There are many types of different AM processes recognized today, which are 
divided into three categories of liquid-based, powder-based, and solid-based systems, 
based on the raw materials used in the process (Chua et al., 2003; Hopkinson et al., 
2006). From all these, the most widely used AM processes include Stereolithography 
(SLA), Fused Deposition Modelling (FDM), Selective Laser Sintering (SLS), 3D 
Printing (3DP), and Laminated Object Manufacturing (LOM) (Grenda, 2006; Liou, 
2008; Wohlers, 2008). 
 
 
2.1.1 Fused deposition modelling (FDM) 
 
 
In recent years, fused deposition modelling (FDM) has become a widely used 
AM technology for various applications in engineering. FDM systems, developed by 
Stratasys Inc., can fabricate parts in a range of materials including elastomers, 
acrylonitrile butadiene-styrene (ABS) and investment casting wax with the layer by 
layer deposition of extruded material through a nozzle using feedstock filaments 
from a spool (Stratasys Inc, 1991). Most of the parts fabricated in these materials can 
be used for design verification, form and fit checking and patterns for casting 
processes and medical application. 
The basic principle of operation of the FDM process offers great potential for 
a range of other  materials, including metals, ceramics, and composites to be 
developed and used in the FDM process as long as the new material can be produced 
in the feedstock filament form of required size, strength, and properties.  
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In FDM, the prototyping process begins with unwinding the feedstock 
filament from a reel and feeding it through the liquefier located inside the system 
working envelope, as shown in Figure 2.1, where it gets gradually heated by 
temperature gradient provided by a number of coils wrapped helically about the axis 
of the liquefier. The heated liquefier melts the plastic filament and deposits the melt 
through a nozzle attached at the exit controlling the diameter of the final extrudate. 
Two step motors at the entrance of liquefier make sure a continuous supply of 
material during the model build-up. The nozzle and liquefied assembly are mounted 
onto a mechanical stage numerically controlled in X-Y plane.  
Upon receipt of precise tool paths prepared by the software, the nozzle moves 
over the platform depositing a thin bead of thermoplastic model material along with 
any necessary support structure. Deposition of fine extruded filaments onto the 
substrate produces a layer corresponding to a slice of the CAD model of the object. 
Once a layer is built the substrate moves down in z direction in order to prepare the 
stage for the deposition of the next layer. The deposited filaments cool down, 
immediately below the glass transition temperature of the polymer and get hardened. 
The entire build system is contained within a temperature-controlled environment 
with temperatures just below the glass-transition temperature of the polymer to 
provide an efficient intra-layer bonding. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Schematic of FDM process, (Levy et al., 2003) 
FILAMENT 
EXTRUDER HEAD 
HEATED NOZZLE 
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Materials used in FDM are non-toxic and inert, synthesized from 
commercially available thermoplastics and waxes. They all vary in strength, rigidity 
and surface finish, providing a wide range of testable models (Stratasys retrieved 
2009). Currently, it can build durable, accurate and strong models from Acrylonitrile 
Butadiene Styrene (ABS), Polycarbonate (PC), and Polyphenylsulfones (PSSF). 
Among these, ABS is the most commonly used material for part fabrication on the 
FDM because of its superior engineering properties. Due to non-toxicity of the 
feedstock materials the process is office-friendly. The material can be easily 
changed, and the waste is negligible. The feedstock material is fed in the form of 
filament with diameters of 1.75± 0.05 mm. Since the size of strands produced as 
building elements of the prototypes is limited to the nozzle tip size, the process can 
have limited accuracy compared to the liquid-based processes such as SLA. Limited 
materials, limited size, and unpredictable shrinkage are the disadvantages of FDM 
technology. 
One of the most demanding areas that gain a lot of interest from the 
researcher is in the biomedical area (Wiria et al., 2007; Tan et al., 2003; Hao et al., 
2006). The increasing trend to incorporate artificial devices into the human body has 
sharply focused attention onto the compatibility of the materials from which such 
devices are made with human physiology. Given that it is widely predicted that more 
and more functions will be taken over by artificial devices, not only for repairing 
damaged function, but also for enhancing function, the need to solve the problem of 
how to design and manufacture such materials to make them maximally compatible 
with living tissue (including biofluids such as blood) has become a major priority of 
the medical device industry. 
 
 
2.2 Biomaterial 
 
 
A biomaterial can be defined as any material used to make devices to replace a part 
or a function of the body in a safe, reliable, economic and physiologically acceptable 
manner. A variety of devices and materials are used in the treatment of disease and 
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injury. A biomaterial also recognized as a synthetic material used to replace part of a 
living system or to function in inmate contact with living tissue.  
Biomaterials in the form of implant are widely used to replace and/or restore 
the function of traumatized tissues or organs, to assist in healing, to improve 
function, and to correct abnormalities. Researchers have used the words ‘biomaterial’ 
and ‘biocompatibility’ to indicate the biological performances of materials 
(Ramakrishna et al., 2004). In order to improve the quality life of patients, the 
design, material selection, and biocompatibility remain as the paramount issues of 
biomaterials for medical applications. Until recently, most of medical devices are 
still made from single phase homogeneous and isotropic materials such as metals, 
ceramics and polymer (Ramakrishna et al., 2004).  
Metallic implants have been used either as permanent prostheses such as the 
hip prosthesis, dental implants, etc., or as temporary implants such as plates, pins, 
screws and rods for the fixation of bone fractures. Metals are known for high 
strength, ductility, and resistance to wear. Cobalt-chromium alloys, stainless steel 
and titanium alloy are common metals that have been extensively used in to fabricate 
the implants due to its strength and toughness that are required in load-bearing parts 
of the body (Long & Rack, 1998). However, many metals are known for its low 
biocompatibility, corrosive, and high density, which may cause allergic tissue 
reaction. Other disadvantages of using metallic implants include the need for the 
second operation to remove temporary implants and these implants are usually not 
integrated by the bone tissue or only after extended implantation periods. 
Bioceramics material with its advantage of being compatible with the human 
body environment has been chosen for tissue substitution since the last 30 years. 
However, the brittleness of ceramics, which are much stiffer than human cortical 
bone lead to mechanical mismatch problems between the existing implant and bone. 
This mismatch of stiffness between the bone and the metallic or ceramic implants 
may lead to lower bone density, and altered bone architecture (Ramakrishna et al., 
2004). The drawback of ceramics also includes low fracture toughness that hinders 
clinical use in load bearing implants (Eniwumide et al., 2004). 
Thus, polymer with its advantages such as available in a wide variety of 
compositions, properties and forms (solids, fiber, and films) can be fabricated readily 
into complex shapes and structures seem to be a promising choice, in particular for 
bone tissue engineering and provide alternative choices to overcome many 
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shortcomings of metals and ceramic material. The main advantages of the polymeric 
biomaterials compared to metal or ceramic, materials are ease of manufacturability to 
produce various shapes, ease of secondary processability, reasonable cost, and 
availability with desired mechanical and physical properties (Lee et al., 2007). Table 
2.1 shows the classifications of biomaterial used in the human body with their 
advantages and disadvantages. 
 
Table 2.1: Classifications of biomaterial as an implant used in the body 
 
Materials 
 
Advantages Disadvantages Examples 
Polymers  
(Nylon, silicone rubber, 
polytetrafuoroethylene, etc.) 
 Resilient 
 Easy to fabricate 
 Not strong 
 Deforms with 
time 
 May degrade 
Sutures, blood 
vessels, hip socket, 
ear, nose other soft 
tissues. 
Metals  
(Ti and its alloys, Co–Cr 
alloys, stainless steels, Au, 
Ag, Pt, etc.) 
 Strong 
 Tough 
 Ductile 
 May corrode 
 Dense 
 Difficult to make  
Joint replacements, 
bone plates and 
screws, dental root 
implants, pacer and 
suture wires. 
Ceramics 
(Aluminum oxide, calcium 
phosphates including 
hydroxyapatite, carbon) 
 Very 
biocompatible 
 Inert 
 Strong in 
compression 
 
 Brittle 
 Not resilient 
 Difficult to make 
Dental and orthopedic 
implants 
 
Composites  
(Carbon–carbon, wire or 
fiber reinforced bone cement) 
 Strong 
 Tailor-made 
 Difficult to make 
Bone cement, dental 
resin 
 
 
 
2.3 Polymeric biomaterial 
 
 
Polymers are long chain molecules that consist of small repeating units. There are 
variety of polymers including natural materials and synthetic polymers. Medical use 
of synthetic polymers has a long history. The great number of currently available 
synthetic polymers makes the selection of a suitable polymer for a particular 
biomedical application a difficult task. However, among all properties required for an 
application, the biocompatibility of the polymer with tissues and biological fluids is 
always the foremost consideration for all candidate materials.  
Many types of polymers are widely used in biomedical devices that include 
orthopedic, dental, soft tissue, and cardiovascular implants. Polymers represent the 
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largest class of biomaterials. Polymers may be derived from natural sources, or from 
synthetic organic processes. Synthetic polymeric biomaterials range from 
hydrophobic, non-water-absorbing materials such as silicone rubber (SR), 
polyethylene (PE), polypropylene (PP), poly(ethylene terephthalate) (PET), 
polytetrafluoroethylene (PTFE), and poly(methyl methacrylate) (PMMA) to 
somewhat more polar materials such as poly(vinyl chloride) (PVC), copoly(lactic–
glycolic acid) (PLGA), and nylons, to waterswelling materials such as 
poly(hydroxyethyl methacrylate) (PHEMA) and beyond, to water-soluble materials 
such as poly(ethylene glycol) (PEG or PEO). Some are hydrolytically unstable and 
degrade in the body while others may remain essentially unchanged for the lifetime 
of the patient. 
 
 
2.3.1  Polycaprolactone 
 
 
Polycaprolactone (PCL) is a bioresorbable polymer with potential 
applications for bone and cartilage repair. PCL has certain advantages relative to 
other polymers such as PLA (poly lactic acid). PCL is more stable in ambient 
conditions; it is signiﬁcantly less expensive and is readily available in large 
quantities. Much research currently focused on the use of PCL biocomposites and co-
polymers of PCL with both natural and synthetic polymers (Azevedo et al., 2003; 
Washburn et al., 2002) 
 Polycaprolactone (PCL) is also used for drug delivery; drug compounds are 
mixed in the polymer matrix and gradually become released as the polymer is 
dissolved in the tissue (Landers et al., 2002; Sachlos & Czernuszka, 2003). In the 
emerging ﬁeld of tissue engineering, biodegradable polymers are used for realizing 
polymer scaffolds to assist tissue and cell growth during formation of artiﬁcial 
organs (Taboas et al., 2003). In such applications, biodegradable polymers have been 
shown to allow successful cell attachment, proliferation, and functioning. 
PCL, an aliphatic polyester that has been intensively investigated as a 
biomedical material (Zhong et al., 2001), demonstrates a low melting point (57°C) 
and a low glass-transition temperature (-62°C). PCL can be degraded by micro-
organisms as well as by a hydrolytic mechanism under physiological conditions (Pitt 
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et al., 1981). Under certain circumstances, it is possible to enzymatically degrade 
crosslinked PCL (termed enzymatic surface erosion). Low molecular-weight 
fragments of PCL are also reportedly absorbed by macrophages intercellularly 
(Woodward et al., 1985). PCL material has a signiﬁcantly slower biodegradation rate 
than other BDP materials, making it suitable for design of long- term implantable 
systems such as apronor, a US FDA- approved contraceptive device (Pitt et al., 
1981). Another interesting property of PCL is its propensity to form compatible 
blends with a wide variety of polymers (Koleske, 1978). The toxicology of PCL has 
been extensively studied as part of the evaluation of Capronor (Pitt et al., 1981); and 
it is currently regarded as non- toxic and tissue compatible. 
Polycaprolactone has been used in extensively in the field of tissue 
engineering. Also, PCL fibers have been proven effective for cell proliferation, 
especially under the cultures of MCF-7 mammary carcinoma (Khil et al., 2005). The 
cultures of the mammary cells had a slow growth during the first few days, however, 
when compared to the control groups, the PCL does improve the cell growth kinetic 
rates over time.  
PCL has become very beneficial in the development of tissue structures for 
bone growth.  Previously, poly (DL-lactide-co-glycolide) (PLGA) has been used for 
developing scaffolds for bone cell growth.  In particular, bone marrow was harvested 
from rats and used in this study (Yoshimoto et al., 2003). Mesenchymal stem cells, 
from the bone marrow, were used upon PCL electrospun scaffolds.  The PLGA used 
previously had only shown limited topical growth and 40% shrinkage in length 
(Yoshimoto et al., 2003).  The usefulness of the PCL can be attributed to the higher 
glass transition temperature (-70°C to -60°C) (Cruz et al., 2005).  
The following section will explain the use of PCL scaffold in varied areas of 
tissue engineering. 
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2.3.1.1 Bone tissue scaffold 
 
 
 The potential used of PCL in bone tissues engineering have been investigated 
by a lot of researchers. Lam et al., (2009) who have investigated a bioactive and 
bioresorable scafoold fabricated from PCL incorporating 20% beta-tricalcium 
phosphate. This studies was further develop for regeneration at load bearing by 
Abbah et al., (2009). From their research, they have found that the PCL-TCP 
scaffold could act as bone graft substitutes by providing act as bone graft substitutes 
by providing a suitable environment for bone regeneration in a dynamic load bearing 
setting such as in a porcinemodel of interbody spine fusion.  
 Choi et al., (2008) carried a work on an electrospun PCL/collagen nanoﬁbers 
of different orientations.which focus on producing functional muscle tissue for 
restoring large skeletal muscle tissue defects. They have fabricated PCL cylindrical 
scaffold to investigate the pore size effect on cell and tissue interactions by 
centrifugation method. In their findings, they have concluded that the pore size 
gradient scaffolds fabricated by this centrifugation method might be considered a 
good tool for the systematic studies of interactions between cells or tissues and 
scaffolds with different pore sizes.  
 There are also work have been done by the National University of Singapore 
on bone research based on medical grade PCL both in vitro and in vivo and have 
been commerciallized after clinical approval in 2008 (Lam et al., 2008). 
 
 
2.3.1.2 Cartilage engineering 
 
 
 Huang et al., (2004) has developed a biphasic implant comprising PCL with 
TGF-β1-loaded ﬁbrin glue to determine whether the implant could recruit 
mesenchymal cells and induce the process of cartilage formation when implanted in 
ectopic sites. PCL scaffolds loaded with various doses of TGF-β1 in ﬁbrin glue were 
implanted subcutaneously, intramuscularly, and subperiosteally and assessed 
histologically 2, 4, and 6 weeks postoperatively. The entire pore spaces of the 
scaffolds were ﬁlled with various tissues in each group. The entire volume of the 
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scaffolds in the groups loaded with TGF-β1 and implanted intramuscularly and 
subcutaneously was populated with mesenchymal cells surrounded with an abundant 
extracellular matrix and blood vessels. The scaffold loaded with TGF-β1 and 
implanted subperiosteally was found to be richly populated with chondrocytes at 2 
and 4 weeks and immature bone formation was identiﬁed at 6 weeks. The study 
concluded that scaffolds loaded with TGF-β1 could successfully recruit 
mesenchymal cells and that chondrogenesis occurred when this construct was 
implanted subperiosteally. 
 Wise et al., (2009) in his research of electrospun oriented PCL scaffolds onto 
which they seeded human mesenchymal stem cells. Cell viability, morphology, and 
orientation on the ﬁbrous scaffolds were quantitatively determined as a function of 
time. While the ﬁber-guided initial cell orientation was maintained even after 5 
weeks, cells cultured in the chondrogenic media proliferated and differentiated into 
the chondrogenic lineage, suggesting that cell orientation is controlled by the 
physical cues and minimally inﬂuenced by the soluble factors. Based on assessment 
by chondrogenicmarkers, they concluded that the use of the nanoﬁbrous scaffold 
enhanced chondrogenic differentiation and indicate that hMSCs seeded on a 
controllable PCL scaffold may lead to an alternate methodology to mimic the cell 
and ECM organization. 
 Shao et al., (2006) fabricated a hybrid scaffold system which comprised 3D 
porous PCL scaffold for the cartilage component and tricalcium phosphate-
reinforced PCL scaffold for the bone portion.They have found a superior repair 
results as compared to the control group using gross examination, qualitative and 
quantitative histology, and biomechanical assessment. The hybrid scaffolds provided 
sufﬁcient support to the new osteochondral tissue formation and the bone 
regeneration were consistently good from 3 to 6 months, with ﬁrmintegration to the 
host tissue. 
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2.3.1.3 Cardiovascular engineering 
 
 
 Van et al., (2006) have developed two types of scaffolds for tissue 
engineering of the aortic valve; an electrospun valvular scaffold and a knitted 
valvular scaffold. These scaffolds were compared in a physiologic ﬂow system and 
in a tissue-engineering process. In ﬁbrin gel enclosed human myoﬁbroblasts were 
seeded onto both types of scaffolds and cultured for 23 days under continuous 
medium perfusion. Tissue formation was evaluated by confocal laser scanning 
microscopy, histology and DNA quantiﬁcation. They concluded that an optimal 
scaffold seems to be a combination of the strength of the knitted structure and the 
cell-ﬁltering ability of the spun structure.  
 Ajili et al., (2009) have used a polyurethane/PCL blend as a proposed 
material for shape memory stents. Polyurethane copolymer based on PCL diol was 
melt blended with PCL in four different ratios of 20, 30, 40 and 50wt.% and their 
shape memory behaviors were examine. They have found that the blend supported 
cell adhesion and proliferation, which indicated good biocompatibility in addition to 
shape memory properties, providing potential use as a stent implant. Wang et al., 
(2004) have studied a gene therapy system to treat hypertension and congestive heart 
failure based on the release of atrial natriuretic peptide (ANP) from ANP-cDNA-
transfected Chinese Hamster Ovary cells which had been encapsulated within PCL 
tubes. The encapsulated cells remained viable during culture and ANP secretion was 
maintained for at least 6 months. 
 
 
2.3.1.4 Skin engineering 
 
 
 Powell & Boyce, (2009) blended PCL with collagen before electrospinning 
the composite to formsubmicron ﬁbers. Tensile testing indicated that the inclusion of 
PCL from 10% to 100% signiﬁcantly improved the strength and stiffness of the 
acellular scaffold. They have also reported that, the epidermal formation and reduced 
cell viability was evident at when the PCL content was increased beyond 10% and 
there was an associated loss of engineered skin construct strength indicating that high 
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cell viability and proper development of the epidermis and important factors for 
developing engineered skin with high strength. 
 A studied by Dai et al., (2004) who produced PCL/collagen composites for 
tissue-engineered skin substitutes an demonstrated good cell attachment and 
proliferation of ﬁbroblasts and keratinocytes. They utilize PCL/collagen blends as 
skin substitutes through seeding human single-donor keratinocytes and ﬁbroblasts 
alone on both sides of the 1:20 biocomposite to allow for separation of two cell types 
and preserving cell signals transmission via micro-pores with a porosity of 28.8 ± 
16.µm. They have also reported that the bi-layered skin substitute exhibite both 
differentiated epidermis and ﬁbrous dermis in vitro. Moreover, fast wound closure 
epidermal differentiation, and abundant dermal collagen deposition were observed in 
composite skin in vivo. 
 Reed et al., (2009) have studied on several cell types (human foreskin 
ﬁbroblasts, murine keratinocytes and periosteal cells) cultured together on PCL 
nanoﬁbers. His work was to produce trilaminar constructs, to reﬂect a compound 
tissue, although clear obstacles exist in maintaining an appropriate interface between 
the tissue types and neo vascularizaion of the composite structure. Chen et al., (2009) 
have used a vacuum seeding technique on PCL electrospun scaffoldswhile using NIH 
3T3 ﬁbroblasts as themodel cell system. Vacuum seeding was used in this study to 
enhance ﬁbroblasts seeding and proliferation at different depths. Results showed that 
the kinetics of cell attachment and proliferation were a function of varying vacuum 
pressure as well as ﬁber diameter.  
 
 
2.3.1.5 Nerve engineering 
 
 
Dendunnen et al., (1993) in his work began evaluating PCL as a composite, 
combined with PLLA in guided nerve regeneration. Cytotoxicity tests, subcutaneous 
biodegradation and an in situ implantation studies in the sciatic nerve of the rat were 
undertaken. The nerve guide copolymer was found to be non-toxic, according to 
ISO/EN standards, and it showed a mild foreign body reaction and complete ﬁbrous 
encapsulation after implantation. 
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 Kim et al., (2008) looked at the role of aligned polymer ﬁber-based constructs 
in the bridging of long peripheral nerve gaps, demonstrating a signiﬁcant role of 
submicron scale topographical cues in stimulating endogenous nerve repair 
mechanisms. Nisbet et al., (2009) assessed axonal inﬁltration and guidance within 
neural tissue-engineering scaffolds, made from PCL, and characterized of the 
inﬂammatory response. The extent of microglial and astrocytic response was 
measured following implantation of electrospun PCL scaffolds into the caudate 
putamen of the adult rat brain. They have found no evidence of microglial 
encapsulation and neurites inﬁltrated the implants, evidence of scaffold neural 
integration.  
 PCL/collagen blends were investigated by Schnell et al., (2007) as a conduit 
for axonal nerve regeneration after peripheral nerve injury. Aligned PCL and 
collagen/PCL nanoﬁbers designed as guidance structures were produced by 
electrospinning and tested in cell culture assays. Both types of eletrospun ﬁbers gave 
good cell migration, neurite orientation and process outgrowth, however the 
collagen/PCL ﬁbers gives a better result compared to pure PCL ﬁbers. They have 
concluded that electrospun ﬁbers comprising a collagen and PCL blend represents a 
suitable substrate for supporting cell proliferation, process outgrowth and migration 
and as such would be a good material for artiﬁcial nerve implants. 
Overall, PCL has been proven effective for the use in tissue engineering 
settings. The biocompatibility with the body has been proven.  The fact the polymer 
is bioresorbable helps with numerous tissue engineering factors. With bioresorbable 
polymers, the fibers provide a back support for the cell growth. Over time in the 
body, the fibers, essentially dissolve and leave the cell growth (sometimes in tissue 
form) in a pure form within the body.  
 
 
2.4 Polymer nanocomposites (PNCs) 
 
 
Reinforcement of polymers with a second organic or inorganic phase to produce a 
polymer composite is common in the production of modern plastics. Material such as 
metals and fiber were the earliest materials added to thermoplastics and thermosets to 
form polymer composites (Krishnamoorti, 2001). 
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One of the primary reasons for adding fillers to polymers is to improve their 
mechanical performance. In traditional composites (refer to micro size filler), 
unfortunately, this often comes at the cost of a substantial reduction in ductility, and 
sometimes in impact strength, because of stress concentrations caused by the fillers 
(Kornmann, 2002). Well-dispersed nano fillers, on the other hand, can improve the 
modulus and strength and maintain or even improve ductility because their small size 
does not create large stress concentrations. In addition, the large interfacial area of 
nanocomposites provides an opportunity for altering the matrix properties in unique 
ways (Kornmann, 2002). 
Advances in synthetic techniques and the ability to readily characterize 
materials on an atomic scale has lead to an interest in reinforcement of polymers with 
nanometer-size materials to create a new class of composites called polymer 
nanocomposites (PNCs) (Brauer, 2000). This new class of materials, exhibits 
superior properties in comparison with pure polymer or conventionally filled 
polymers and the properties can be achieved at a much lower volume fraction of 
reinforcement, normally less than 5% by weight (Vaia, 2002). As reported by NPL 
(2004), PNCs in general, with 2 vol% addition, can increase properties in tensile 
strength (>40%), tensile modulus (>70%), flexural strength (>60%), flexural 
modulus (>125%), heat distortion temperature (65º-150ºC), lower water sensitivity 
and permeability to gas, excellent flame retardancy, UV resistance, and barrier 
properties.  
PNCs are commonly defined as particle-filled polymers for which at least one 
dimension (i.e. length, width, or thickness) of the dispersed particles is in the 
nanometer size range, generally at less than 100nm (Vollath & Szabo, 2004). They 
were developed in the late 1980s in both commercial research organizations and 
academic laboratories. The first company to commercialize these nanocomposites 
was Toyota (Richard et al., 2002), which used them for timing belts in their car 
engine components. Since then, the number of commercial applications for 
nanocomposites has grown at a rapid rate. Several potential applications have been 
identified in the following industrial sectors. More detail on specific applications can 
be found in Fischer (2003): 
a. Automobile (gasoline tanks, bumpers, interior and exterior panels, 
etc) 
b. Construction (shaped extrusions, panels) 
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c. Electronics and electrical (printed circuits, electric components) 
d. Food packaging (containers, films) and 
e. Aerospace (flame retardant panels and high performance components) 
 
Most commercial interest in PNCs has focused on thermoplastics. 
Thermoplastics can be broken down into two groups: less expensive and more 
expensive (higher performance) commodity resins. Hence, one of the goals of PNCs 
was to allow the substitution of more expensive engineering resins with a less 
expensive commodity resin nanocomposite (Vaia, 2002). Substituting a 
nanocomposite commodity resin with equivalent performance for a more expensive 
engineering resin should yield overall cost saving. Another goal for PNCs is 
providing lighter weight alternatives to conventionally-filled polymer (Manias, 
2004). 
 
 
2.4.1 Layered silicates 
 
 
The layered silicates or clay commonly used in nanocomposites belong to the 
structural family known as the 2:1 phyllosilicates and the most commonly used 
layered silicates are montmorillonite (MMT). It was discovered in 1847 in 
Montmorillon in the Vienne, France. Clays have been extensively used in the 
polymer industry as fillers to reduce the amount of the polymers used in shaped 
structures, thereby lowering the high cost of the polymer systems.f The efficiency of 
the clay as a reinforcing agent to modify the physicomechanical properties of the 
polymer is determined by the degree of its dispersion in the polymer matrix, which in 
turn depends on its particle size (Akelah et al., 1995). Natural clays may contain 
divalent cations such as calcium and require expensive exchange procedures with 
sodium prior to further treatment with onium salts (Zanetti et al., 2000). 
Pristine layered silicates usually contain hydrated Na+ or K+ ions. Obviously, 
in this pristine state, layered silicates are only miscible with hydrophilic polymers, 
such as poly (ethylene oxide) (PEO), or poly (vinyl alcohol) (PVA). To render 
layered silicates miscible with other polymer matrices, one must convert the 
normally hydrophilic silicate surface to an organophilic one, making the intercalation 
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of many engineering polymers possible. Generally, this can be done by ion-exchange 
reactions with cationic surfactants including primary, secondary, tertiary, and 
quaternary alkylammonium or alkylphosphonium cations. alkyl-ammonium or 
alkylphosphonium cations in the organosilicates lower the surface energy of the 
inorganic host and improve the wetting characteristics of the polymer matrix, and 
result in a larger interlayer spacing. Additionally, the alkylammonium or 
alkylphosphonium cations can provide functional groups that can react with the 
polymer matrix, or in some cases initiate the polymerization of monomers to improve 
the strength of the interface between the inorganic and the polymer matrix (Sinha & 
Okamoto, 2003). 
 
 
2.4.1.1 Dispersion state of layered silicates 
 
 
The dispersion state of PNC’s is depending on how many dimensions of the 
dispersed phase are in the nanometer range, one can distinguish three different 
nanocomposites can be reinforced by isodimensional phases, which have three 
dimensions in the nanometer range such as precipitated silica, silica-titania oxides 
synthesized by the sol gel process, silica beads but also colloidal dispersion of rigid 
polymers, and many others. They can also be reinforced by a phase which has only 
two dimensions at the nanometer scale. It is the case of polymer matrices reinforced 
by cellulose whisker or nanotubes. The third type of nanocomposites corresponds to 
the case where the reinforcing phase, in the shape of platelets, has only one 
dimension on a nano level. Polymer-layered silicate nanocomposites belong to this 
third class (Alexandre & Dubois, 2000). 
Conventional composite or microcomposite where the layered silicate acts as 
a conventional filler, intercalated nanocomposites consisting of a regular insertion of 
the polymer in between the silicate layers and exfoliated or delaminated 
nanocomposites where 1 nm-thick layers are dispersed in the matrix forming a 
monolithic structure on the micro scale. Because thermoset-layered silicate 
nanocomposites are synthesized by in-situ polymerization, silicate layers separated 
by 5 to 10 nanometers remain parallel if the extent of intragallery polymerization is 
uniform. Nanocomposites presenting such structure with long-range order have also 
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Polymer      or     Monomer 
+ 
Clay layes 
(a) Conventional composites 
(b) Intercalated Nanocomposites 
(c) Exfoliated Nanocomposites 
been considered as exfoliated. The exfoliated configuration is of particular interest 
because it maximizes the polymer-layered silicate interactions, making the entire 
surface of the layers available for interactions with the polymer. This should lead to 
more dramatic changes in mechanical and physical properties (Alexandre & Dubois, 
2000). 
Depending on the nature of the components used (layered silicate, organic 
cation and polymer matrix) and the method of preparation, three main types of 
composites may be obtained when layered clay is associated with a polymer as 
shown in Figure 2.2 (Alexandre & Dubois, 2000). Conventional composite is 
obtained if the polymer cannot intercalate into the galleries of clay minerals. The 
properties of such composite are similar to that of polymer composites reinforced by 
micro particles. There are two extreme nanostructures resulting from the mixing of 
clay minerals and a polymer providing a favor conditions. One is intercalated 
nanocomposite (Figure 2.2a), in which monolayer of extended polymer chains is 
inserted into the gallery of clay minerals resulting in a well ordered multilayer 
morphology stacking alternately polymer layers and clay platelets and a repeating 
distance of a few nanometers. The other is exfoliated or delaminated nanocomposite 
(Figure 2.2b), in which the clay platelets are completely and uniformly dispersed in a 
continuous polymer matrix. However, it should be noted that in most cases the 
cluster (so-called partially exfoliated) nanocomposite (Figure 2.2c) is common in 
polymer nanocomposites (Zeng et al., 2005). 
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